Dr. Ashwini Raghu holds a Bachelor of Ayurvedic Medicine and Surgery (BAMS) degree from the prestigious Government Ayurvedic Medical College in Bangalore. She furthered her expertise by obtaining a Doctor of Medicine (MD) degree, solidifying her in-depth knowledge and proficiency in the Ayurvedic medical system.

In addition to her Ayurvedic practice, Dr. Ashwini Raghu is a certified nutritionist. She integrates her knowledge of nutrition with Ayurvedic principles to provide comprehensive dietary advice and lifestyle modifications, promoting overall well- being and disease prevention. Dr. Ashwini Raghu is currently advancing her academic qualifications by pursuing a Master's degree in Neuroscience at Dukes University, Europe.

Dr. Ashwini Raghu is a dedicated philanthropist who operates a unique and compassionate healthcare initiative known as the "Pay What You Can Clinic." At this clinic, patients are not required to pay a set fee for services. Instead, they can contribute an amount they are comfortable with after receiving satisfactory treatment. This model ensures that high-quality Ayurvedic healthcare is accessible to everyone, regardless of their financial situation.

Ashwini Raghu is deeply involved in initiatives that support the education of underprivileged children. Her commitment to giving back to the community is demonstrated through her active participation in numerous educational programs and charitable organizations.

Mr. Raghu Rangaswamy, a seasoned leader with over 25 years of experience in Business Development and Scientific research, spearheads our team of experts. He played a pivotal role in the successful launch of Molecular Operating Environment software (MOE) and Schrodinger software in India, building the business from Scratch to millions of USD. He also conducted user group meetings for more than 1500 participants inviting heads for R&D and Vice Chancellors from Universities. His exceptional academic background in Pharmacy, Biotechnology, and Bioinformatics, coupled with an MBA, fuels his unique techno-commercial approach and marketing acumen.

Raghu Rangaswamy also held diverse roles as a Scientist at DSQ Biotech and Biocon, an Assistant Professor at PSG Medical College, and a Medical Representative at Bayer and Tata Pharma. This diverse experience instilled in him a deep understanding of the scientific community’s needs and challenges.

Raghu Rangaswamy’s expertise extends beyond the commercial realm. He is a sought-after speaker at national and international conferences, serves on the advisory boards of leading Indian universities, and actively contributes to philanthropic initiatives, particularly those focused on rural children’s education and supporting individuals with disabilities.

He is the trustee and Vice President of Friends of Camphill India Trust and Vice President of Vallal V. Dasappa Gowder old boys’ association trust which is involved in educating children.

Dr Vellarkad Viswanadhan has over thirty-five years of Pharmaceutical industry and professional experience in USA (Amgen, National Cancer Institute, Gensia- Psicor) and in India (Jubilant Biosys) in the fields of Computational drug design, Molecular Modeling and Informatics. As the Vice President of Computational Chemistry and Informatics at Jubilant Biosys, he has led drug discovery and informatics projects and mentored research scientists supporting Drug Discovery, Chemical Database and Computational methods/tools development.

For several years, he was extensively involved in engaging of MNCs as the Executive Sponsor for planning, executing and delivering milestone-based Drug Discovery, Informatics, Medicinal and Computational Chemistry projects. The drug discovery projects he worked on include cancer, pain & inflammation, Alzheimer’s disease, and metabolic disorders.

Dr Viswanadhan has extensively published (76 research articles and over 15 patents / applications; Close to 10000 citations in total). He has served as a reviewer for journals and member to Board of Studies of universities and offered Guidance for MS & Ph.D Students.

He was named as belonging to the list of top 2% of scientists in the world for the past 3 years:

Bibliography Link :

Dr. Chitraa Tangavel, a Clinical Scientist with 25 plus years of experience and has a wide exposure in the biotechnological industry, education, and research, particularly in the realms of OMICS platform especially metagenomics, proteomics and metabolomics. Her significant contributions have propelled advancements in deciphering system biology during the progress of musculoskeletal diseases especially Intervertebral disc disease, Osteoarthritis and Rheumatoid arthritis showcasing her leadership and expertise.

In proteomics and metabolomics, Dr. Tangavel’s has a good expertise in coupling advanced proteomics sequencing with computational approaches for the integration of OMICS platforms, to unravel molecular insights underlying inflammation, degenerative disc disease, fungal keratitis, and metabolic disorders.

Dr. Tangavel’s research stands out for her innovative approach, especially in exploring the dynamic interactions between host cells and the microbiome within the disc environment using OMICS platforms. The integration of proteomics has enabled her to unravel the complexities of microbial communities associated with disc health, contributing significantly to this field.

In academia, Dr. Tangavel demonstrates a strong commitment to education by mentoring students and contributing to academic leadership. Her pivotal role in establishing research facilities spans biochemistry, cell culture, proteomics, metabolomics, and genomics, underscoring her impact across multiple domains. With a prolific publication record and acquaintance with innovative biomarker discovery platforms, Dr. Tangavel emerges as a significant contributor to understanding biological processes.

Her dedication is evident in her holistic approach, utilizing both wet lab experimentation and cutting-edge computational methods on the OMICS platform. This multifaceted approach positions her as a key figure shaping the future of personalized therapeutic interventions, showcasing her enduring impact on the intersection of biotechnology and computational biology.

Dr. V. Subramanian is a distinguished scholar and honorary consultant in Theoretical Chemistry, Computational Chemistry, and Computational Biology. With an impressive academic and research career spanning several decades, he is currently serving as a Visiting Faculty at the Department of Chemistry, Indian Institute of Technology Madras. His extensive tenure at the CSIR-Central Leather Research Institute from 1994 to 2022 exhibits his commitment to advancing scientific knowledge and research.

Dr. Subramanian's expertise lies in the characterization of non-covalent interactions in molecular clusters and self-assemblies, development of Conceptual DFT based descriptors for QSAR and QSTR applications, and the exploration of sequence, structure, stability, and function interrelationships in proteins, particularly collagen. His research also extends to developing force field parameters for metalloproteins and enzymes and investigating the interactions of nanomaterials with macromolecules at the atomic and molecular levels.

His theoretical work on functional materials has significant implications for hydrogen storage, OLEDs, dye-sensitized solar cells, and novel 2D Dirac materials for energy applications. Dr. Subramanian's scientific contributions are well-recognized, with 24 Ph.D. students supervised, 317 publications, over 6,740 citations, and an h-index of 43. His accolades include the CRSI–Young Scientist Award (2003), CRSI Bronze Medal (2008), and Fellowships at both the National Academy of Sciences, Allahabad (2013), and the Indian Academy of Science, Bangalore (2014).

Dr. Subramanian's pioneering work in Theoretical and Computational Chemistry has provided deep insights into the non-covalent interactions within molecular systems, the structure and reactivity of biomolecules, and the design of novel materials for energy applications. His dedication to research and education continues to inspire and influence the scientific community.

Anbu Dinesh Jayakumar is a Computational Chemist with nearly three years of industrial experience at Jubilant Biosys, Bengaluru, he has worked in various small molecule drug discovery projects, using advanced computational tools to drive progress.

Anbu holds an M. Pharm in Pharmaceutical Chemistry from The Tamilnadu Dr. MGR Medical University. His M. Pharm project won the State-Level First Award from the Tamilnadu Pharmacy Welfare Trust, Chennai.

Currently, he works as an Application Scientist, where he is involved in promoting and doing pre and post sales training on the computational chemistry software solutions marketing by Molecular Solutions. Besides his scientific work, he is also involved research and helps the business development team. He is passionate about reading the latest articles and updating his knowledge and learning the software used in drug discovery and development.